Table 4.

The effects of palmvitee supplementation on lymphocyte proliferative presented as stimulation index (S.I.) after induction with mitogen, PHA and Con A in nonsmokers and smokers according to the number of cigarettes per day

Weeks	S1		S2		S3
	Placebo, n = 4	Palmvitee, n = 3	Placebo, n = 17	Palmvitee,n = 19	Placebo, n = 7	Palmvitee,n = 8
	Con A (SI)
0	37.75 ± 15.73	24.50 ± 21.92	80.00 ± 48.12	55.26 ± 30.92	61.00 ± 15.41	53.75 ± 39.75
12	39.25 ± 15.09	55.00 ± 35.59	53.50 ± 35.02	59.32 ± 40.01	39.29 ± 20.77	61.63 ± 28.52*
24	36.00 ± 32.65	22.00 ± 24.56	46.24 ± 28.03	49.26 ± 35.55	36.00 ± 20.94	35.75 ± 26.99
	PHA (SI)
0	58.00 ± 39.30	26.50 ± 6.36	73.17 ± 40.22	70.21 ± 44.99	67.29 ± 29.84	44.60 ± 28.53
12	60.50 ± 24.96	51.67 ± 30.62	69.44 ± 40.09	76.58 ± 35.20	60.29 ± 28.19	81.00 ± 38.53
24	59.25 ± 24.07	72.67 ± 69.82	74.71 ± 44.45	78.47 ± 68.50	62.29 ± 27.49	75.50 ± 32.96

Results are shown as means ± SD. * indicates significant difference as compared to nonsmokers.